Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2025)

Neuroone Medical Technologies' Other Non-Current Liabilities history spans 6 years, with the latest figure at $806859.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 53.92% year-over-year to $806859.0; the TTM value through Dec 2025 reached $806859.0, down 53.92%, while the annual FY2025 figure was $1.3 million, 40.81% down from the prior year.
  • Other Non-Current Liabilities reached $806859.0 in Q4 2025 per NMTC's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.1 million in Q3 2024 to a low of $83333.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 3 years is $1.2 million, with a median of $1.3 million recorded in 2025.
  • The largest YoY upside for Other Non-Current Liabilities was 40.81% in 2025 against a maximum downside of 53.92% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $83333.0 in 2021, then soared by 2001.05% to $1.8 million in 2024, then plummeted by 53.92% to $806859.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Other Non-Current Liabilities are $806859.0 (Q4 2025), $1.3 million (Q3 2025), and $1.0 million (Q2 2025).